Insulin Nation

OCTOBER 16, 2015

One of the biggest pharmaceutical companies is placing a big bet that nasal glucagon is going to get FDA approval in the near future. Eli Lilly and Co. has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. As is often the case in such announcements, financial terms have not yet been disclosed, and both companies have given generic quotes about how the deal was a good thing for everyone.

Pharmaceuticals 97

Pharmaceuticals Drug Development 97

American Well

OCTOBER 13, 2015

Dr. Alan Pitt‘s latest blog takes us on a quick trip down memory lane when patient records were 100% paper, difficult to decipher and virtually inaccessible. This resulted in huge delays in care, among other issues due to the hours of work often needed to find and understand a patient’s medical history. Fortunately, a lot has changed due to computers and federal regulations.

Telemedicine 48

Telemedicine 48

ACA Times

OCTOBER 16, 2015

If You Don’t Have SSNs, Keep Asking for Them. Many of the forms employers will have to file with the IRS early in 2016 ask for Social Security or taxpayer identification numbers — not just of employees, but often of their dependents as well. If employers don’t provide these numbers, the IRS can impose penalties of up to $250 per incomplete or inaccurate return, say Meredith Silliman and Chris Rylands of the law firm Bryan Cave.

40

40

Healthcare Exchange Standards

OCTOBER 16, 2015

The expectation that the IHE ITI Technical Committee had on formatCodes was that the Affinity Domain would not want random and unspecified documents registered. As documents that can't be understood by Document Consumers are not helpful to the Affinity Domain. The Affinity Domain, which is some kind of an organization, would have some Process where those that had a new format would argue the usefulness of their document format.

HIE 40

HIE Health Information 40

Advertisement

Colington Consulting was established in 2013 and helps organizations achieve HIPAA compliance and ensures clients stay current with the latest enforcement trends. We provide a full range of HIPAA compliance services and consulting. What separates us from our competitors is our knowledge of HIPAA compliance regulations and their application to each of our client’s particular scenarios and requirements.

HIPAA

Insulin Nation

OCTOBER 14, 2015

A new study finds that people with diabetes in the U.S. are paying between 5.7 times and 7.5 times more than those in the UK for two popular insulins and a rare drug to treat diabetic retinopathy. U.S. consumers absorb this higher cost despite often not being the first in line to have access to new drugs or medical device treatments. According to a Reuters report , researchers from the University of Liverpool (UK) analyzed the drug prices for 20 top-selling drugs worldwide, including Sanofi’s La

Pharmaceuticals 86

Pharmaceuticals 86

ACA Times

OCTOBER 15, 2015

The Department of Health and Human Services set a goal for 2016 of signing up 10 million Americans for health insurance through state and federal marketplaces established under the Affordable Care Act. That’s about 10% more than the expected total for 2015. HHS believes more than 1 out of 4 uninsured marketplace-eligible consumers will select plans during the open enrollment period, which begins November 1.

Medicare 40

Medicare 40

Healthcare Exchange Standards

OCTOBER 15, 2015

I am asked how someone can get engaged with developments in Privacy/Security around FHIR. I am very happy that people want to help. I am especially encouraging to anyone that has either coding experience, or deployment experience; as I find that too many people engaged in Privacy/Security around FHIR are coming from the theoretical perspective. This is a good perspective, but not sufficient to give us practical solutions.

FHIR 40

FHIR 40

Insulin Nation

OCTOBER 16, 2015

What if you could ask your Type 1 diabetes for a day off, say, on Halloween? In this fanciful flight of fiction, we imagine such a scenario: News quickly spread throughout the diabetes online community that Type 1 diabetes has decided to give 15-year-old Jimmy Smith of Pougensburg, Pennsylvania all Halloween off to lackadaisically consume candy without counting carbs or needing to bolus.

75

75

Insulin Nation

OCTOBER 14, 2015

A new study finds that people with diabetes in the U.S. are paying between 5.7 times and 7.5 times more than those in the UK for two popular insulins and a rare drug to treat diabetic retinopathy. U.S. consumers absorb this higher cost despite often not being the first in line to have access to new drugs or medical device treatments. According to a Reuters report , researchers from the University of Liverpool (UK) analyzed the drug prices for 20 top-selling drugs worldwide, including Sanofi’s La

Pharmaceuticals 60

Pharmaceuticals 60

Advertisement

Effective collaboration among all care team members is critical to delivering better patient outcomes. A key element to achieving effective collaboration is through the implementation of a clinical communication and collaboration platform. In a fast-paced, high-stress and critical environment, people tend to do whatever gets the job done. Therefore will scramble and use the systems, people, or processes around them to get an outcome more quickly - which can often be at the expense of quality.

Insulin Nation

OCTOBER 16, 2015

One of the biggest pharmaceutical companies is placing a big bet that nasal glucagon is going to get FDA approval in the near future. Eli Lilly and Co. has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. As is often the case in such announcements, financial terms have not yet been disclosed, and both companies have given generic quotes about how the deal was a good thing for everyone.

Pharmaceuticals 52

Pharmaceuticals Drug Development 52

Insulin Nation

OCTOBER 16, 2015

What if you could ask your Type 1 diabetes for a day off, say, on Halloween? In this fanciful flight of fiction, we imagine such a scenario: News quickly spread throughout the diabetes online community that Type 1 diabetes has decided to give 15-year-old Jimmy Smith of Pougensburg, Pennsylvania all Halloween off to lackadaisically consume candy without counting carbs or needing to bolus.

41

41

Insulin Nation

OCTOBER 16, 2015

One of the biggest pharmaceutical companies is placing a big bet that nasal glucagon is going to get FDA approval in the near future. Eli Lilly and Co. has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. As is often the case in such announcements, financial terms have not yet been disclosed, and both companies have given generic quotes about how the deal was a good thing for everyone.

Pharmaceuticals 40

Pharmaceuticals Drug Development 40

ACA Times

OCTOBER 14, 2015

Contrary to predictions by critics of the Affordable Care Act prior to its implementation, the healthcare law has not caused employers to cut the number of their employees or reduce the hours they work. That is the conclusion of a study by the Federal Reserve Bank of New York. In fact, states like Texas, which had high levels of uninsurance among workers prior to the ACA, have experienced higher growth in employment, salaries and productivity since the law’s enactment than comparable areas that

40

40

Advertisement

Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, introduces HeartKit, its latest addition to neuralSPOT. This optimized AI model enables running various real-time heart monitoring applications to help users and their healthcare providers quickly identify any irregular events to take necessary actions.

Insulin Nation

OCTOBER 14, 2015

A new study finds that people with diabetes in the U.S. are paying between 5.7 times and 7.5 times more than those in the UK for two popular insulins and a rare drug to treat diabetic retinopathy. U.S. consumers absorb this higher cost despite often not being the first in line to have access to new drugs or medical device treatments. According to a Reuters report , researchers from the University of Liverpool (UK) analyzed the drug prices for 20 top-selling drugs worldwide, including Sanofi’s La

Pharmaceuticals 40

Pharmaceuticals 40

Healthcare Exchange Standards

OCTOBER 13, 2015

Glen Marshall is well known in Healthcare Security circles, and he continues to contribute in Retirement. He produced this use-case and I found it so well written, and it explains Security Audit Logging (FHIR AuditEvent ) as distinct from Provenance (FHIR Provenance ) so well, that I asked him if I could publish it as a guest post. I got his approval almost a month ago, so here it is.

FHIR 40

FHIR 40

ACA Times

OCTOBER 12, 2015

A majority of likely voters in five key battleground states – Florida, Nevada, Ohio, Pennsylvania and Virginia – believe the Affordable Care Act is here to stay (64%) and want Congress to work to improve the law (71%) rather than repeal it. The survey found that 55% of these voters said they prefer a candidate who will work to improve the law, while 40% favor one who would repeal it.

Medicare 40

Medicare 40